The portability and power available on the iPad makes Apple's little machine that could a source of incredible opportunity in the medical diagnostic The portability and power available on the iPad makes Apple's little machine that could a source of incredible opportunity in the medical diagnostic.
New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease
The first episode of MS typically strikes in early adulthood and the disease advances over the years to devastating disability. Depending on where the inflammation occurs – the brain, spinal cord or optic nerves – patients can develop muscle weakness
Pooled Trial Data: Oral Drug Highly Effective in Relapsing-Remitting MS
Delayed-release dimethyl fumarate (Tecfidera) was associated with significant reductions in disability progression, relapse risk, and neuroradiological disease activity over 2 years in relapsing-remitting multiple sclerosis (RRMS), according to a placebo
Roche secures FDA approval for Ocrevus for two types of MS
Most multiple sclerosis patients have the relapsing/remitting form of didn’t show signs of disease activity — defined by no relapses, no confirmed disability progression, and no new or enlarging MRI lesions — compared with Merck KGaA’s